Buildit's Profile
Displaying 401-450 of 2000 result(s).
01/08/2021 2:28:34 PM
01/07/2021 2:45:42 PM
01/07/2021 2:34:45 PM
01/07/2021 1:37:11 PM
01/07/2021 12:48:49 PM
01/07/2021 12:42:38 PM
01/07/2021 12:29:29 PM
01/06/2021 9:46:48 PM
01/06/2021 4:12:59 PM
01/06/2021 1:45:58 PM
01/06/2021 12:29:21 PM
01/05/2021 1:25:53 PM
01/05/2021 1:15:15 PM
01/05/2021 12:46:40 PM
01/05/2021 10:27:42 AM
01/05/2021 10:07:23 AM
01/04/2021 3:13:38 PM
01/03/2021 6:35:20 PM
01/02/2021 9:15:06 PM
12/31/2020 10:56:29 AM
12/31/2020 10:10:16 AM
12/31/2020 9:56:43 AM
12/29/2020 3:58:50 PM
12/28/2020 9:49:25 AM
12/28/2020 9:41:13 AM
12/28/2020 9:24:31 AM
12/28/2020 9:23:05 AM
12/23/2020 11:56:09 AM
12/22/2020 11:24:33 AM
12/22/2020 10:25:11 AM
12/22/2020 10:23:04 AM
12/22/2020 10:20:03 AM
12/21/2020 6:07:51 PM
12/21/2020 5:56:54 PM
12/21/2020 5:53:48 PM
12/21/2020 5:50:54 PM
12/21/2020 5:21:44 PM
12/18/2020 7:33:29 PM
12/18/2020 5:18:24 PM
12/18/2020 4:11:24 PM
12/18/2020 11:26:48 AM
12/18/2020 9:21:14 AM
12/17/2020 3:43:13 PM
12/16/2020 9:10:55 PM
12/16/2020 1:39:34 PM
12/15/2020 5:02:41 PM
12/15/2020 3:37:29 PM
12/15/2020 3:11:38 PM
12/15/2020 3:05:04 PM
12/15/2020 2:53:32 PM
Go to page:
Recent Articles
- Johnson & Johnson's IMAAVY Hits Myasthenia Gravis Market
- Cohen & Steers Total Return Realty Fund Updates for Investors
- SFC Enhances Community Engagement with New Ice Rink Management
- Boehringer Ingelheim Unveils Promising Cancer Trials at ASCO 2025
- Soleno Therapeutics Advances in Treating Hyperphagia for PWS
- Embracing Peace Through Collective Prayer and Support
- Understanding Distribution Sources for Cohen & Steers' Fund
- Innovative Cancer Research from RWJBarnabas Health Surfaces
- Abeona's ZEVASKYN Breakthrough: A New Hope for DEB Patients
- Silvercorp Exhibits Strong Fiscal Year-End Performance 2025
- Univest Securities Completes $5 Million Offering for WORK Medical Tech
- Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
- Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
- Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
- Daktronics Engages at Leading Investor Conference This May
- Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
- IMUNON Seeks to Withdraw Registration Amid Growth Plans
- Abcourt Mines Inc. Reports Solid Third Quarter Progress
- PDS Biotech Shares Positive Results for Versamune® HPV Treatments
- Servotronics' Proxy Contest Conclusion and Upcoming Meeting
- Haivision to Unveil Financial Insights for Q2 Fiscal 2025
- M-tron Industries, Inc. Announces Upcoming Investor Meeting
- Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
- Investors Can Join Digimarc Corporation Class Action Today
- ImCheck Therapeutics Showcases Promising AML Therapy Results
- Legend Biotech Reveals Significant Updates in Cancer Treatment
- ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
- Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
- Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
- Acceleware Ltd. Achieves Significant Progress in Q1 2025
- Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
- Petrus Resources Shares Success of Annual Meeting Outcomes
- Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
- Candel Therapeutics Advances Localized Prostate Cancer Treatment
- Adagene Showcases Promising Results for ADG126 in Cancer Trials
- Banco Comercial Português Highlights Key AGM Resolutions
- Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
- Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
- Accent Therapeutics Showcases Innovative Cancer Treatment Advances
- Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
- Ontario International Airport Sees Record Passenger Growth
- Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
- XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
- Servier Showcases Commitment to IDH-Mutated Cancer Research
- West Fraser Timber's Commitment to Sustainability in 2024
- Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
- Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
- Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
- COOFANDY Celebrates a Decade of Excellence with Major Awards
- Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
